- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07816003
Machine Learning Prediction of Spinal Anaesthesia Block Duration
13 settembre 2026 aggiornato da: SalahEldin Ahmed Abdelaziz Ahmed, Specialized Medical Center (SMC)
Artificial Intelligence-Based Prediction of Sensory and Motor Block Duration Following Spinal Anaesthesia: A Prospective Observational Prediction Model Development Study
The duration of sensory and motor block after spinal anaesthesia varies widely between patients given the same dose of local anaesthetic.
Much of this variability is explained by differences in lumbosacral cerebrospinal fluid volume, which cannot be measured routinely in clinical practice but is related to simple body measurements such as abdominal circumference and vertebral column length.
This prospective observational study will develop and internally validate prediction models for the duration of sensory and motor block following spinal anaesthesia in adults undergoing elective surgery.
Preoperative clinical and anthropometric variables will be recorded, and block regression will be assessed serially after intrathecal injection.
Machine learning methods (lasso regression, ridge regression, random forest, extreme gradient boosting, and support vector regression) will be developed and compared against multivariable linear regression as the reference model.
The aim is a practical tool that helps anaesthetists anticipate how long a spinal block will last in an individual patient, supporting decisions about case scheduling, supplementation, and discharge planning.
Panoramica dello studio
Stato
Non ancora reclutamento
Descrizione dettagliata
Background.
Spinal anaesthesia produces block of unpredictable duration.
Cerebrospinal fluid volume in the lumbosacral region is the dominant determinant of block spread and regression, and correlates inversely with abdominal circumference and directly with vertebral column length.
Existing single-variable rules perform poorly, and no validated multivariable model is in routine clinical use.
Objectives.
The primary objective is to develop and internally validate models predicting the duration of sensory block and the duration of motor block after single-shot spinal anaesthesia.
The secondary objective is to compare the predictive performance of machine learning approaches with conventional multivariable linear regression.
Design.
Single-centre prospective observational cohort study.
No study-directed intervention is applied; anaesthetic technique, drug, and dose are determined by the attending anaesthetist according to routine practice and are recorded as candidate predictors.
Assessments.
Sensory block level is assessed bilaterally by pinprick with a 25-gauge needle along the mid-clavicular line, over dermatomes T4 to S1. Motor block is assessed using the modified Bromage scale (0-3).
Assessments are performed at fixed intervals from intrathecal injection until complete regression of sensory and motor block.
Candidate predictors.
Age, sex, height, weight, body mass index, abdominal circumference, vertebral column length, ASA physical status, local anaesthetic dose and baricity, and adjuvant use.
Sample size.
A target of 255 participants was derived using the Riley criteria for continuous-outcome prediction models (pmsampsize), assuming 9 candidate predictors, an outcome standard deviation of 40 minutes, anticipated R-squared of 0.35, shrinkage of at least 0.90, and a multiplicative margin of error of 1.10.
The four criteria yielded 183, 183, 234, and 246; the largest requirement of 246 was inflated by approximately 4 per cent for attrition.
Analysis.
Model development will use nested repeated 10-fold cross-validation with bootstrap optimism correction.
Performance will be reported as R-squared, root mean squared error, and mean absolute error, with calibration plots.
SHAP values will be used to describe predictor contributions.
Reporting will follow TRIPOD+AI.
Tipo di studio
Osservativo
Iscrizione (Stimato)
255
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Contatto studio
- Nome: Salaheldin A Abdelaziz Ahmed
- Numero di telefono: +966508818713
- Email: saladin28.sa@gmail.com
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
No
Metodo di campionamento
Campione non probabilistico
Popolazione di studio
Consecutive adults scheduled for elective surgery under single-shot spinal anaesthesia at Specialized Medical Center, King Fahad campus, Riyadh.
Descrizione
Inclusion Criteria:
- Adults scheduled for elective surgery under single-shot spinal anaesthesia
- ASA physical status I to III
- Written informed consent obtained
Exclusion Criteria:
- Contraindication to neuraxial anaesthesia (coagulopathy, local or systemic infection, raised intracranial pressure, patient refusal)
- Failed or incomplete block requiring conversion to general anaesthesia
- Repeated or top-up intrathecal injection
- Pregnancy
- Known spinal deformity or previous spine surgery
- Pre-existing neurological or neuromuscular disease affecting sensory or motor assessment
- Inability to cooperate with sensory and motor assessment
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Duration of sensory block
Lasso di tempo: Up to 8 hours after intrathecal injection
|
Time from completion of intrathecal injection to regression of sensory block to the S1 dermatome, assessed bilaterally by pinprick with a 25-gauge needle along the mid-clavicular line
|
Up to 8 hours after intrathecal injection
|
|
Duration of motor block
Lasso di tempo: Up to 8 hours after intrathecal injection
|
Time from completion of intrathecal injection to return to modified Bromage score 0 (full ability to flex knee and ankle)
|
Up to 8 hours after intrathecal injection
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Predictive performance of machine learning models
Lasso di tempo: Through study completion, an average of 20 months
|
R-squared, root mean squared error, mean absolute error, and calibration slope for lasso regression, ridge regression, random forest, extreme gradient boosting, and support vector regression, each compared with multivariable linear regression as the reference model
|
Through study completion, an average of 20 months
|
|
Time to peak sensory block level
Lasso di tempo: Up to 30 minutes after intrathecal injection
|
Time from intrathecal injection to the highest dermatomal level of sensory block, assessed by pinprick
|
Up to 30 minutes after intrathecal injection
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Salaheldin A abdelaziz Ahmed, Specialized Medical Center
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Stimato)
1 dicembre 2026
Completamento primario (Stimato)
1 luglio 2028
Completamento dello studio (Stimato)
1 settembre 2028
Date di iscrizione allo studio
Primo inviato
7 settembre 2026
Primo inviato che soddisfa i criteri di controllo qualità
7 settembre 2026
Primo Inserito (Effettivo)
11 settembre 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
15 settembre 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
13 settembre 2026
Ultimo verificato
1 settembre 2026
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- IRBSMC1-2026-0001
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
SÌ
Descrizione del piano IPD
De-identified individual participant data underlying published results, together with the data dictionary and model code, will be made available to researchers whose proposed use has been approved by an independent review committee.
Requests should be directed to the principal investigator.
Data will be available from 6 months to 36 months after publication of the primary results.
Periodo di condivisione IPD
Data will become available 6 months after publication of the primary results and will remain available for 36 months
Criteri di accesso alla condivisione IPD
Requests should be directed to the principal investigator.
Proposals will be reviewed by the principal investigator and the Specialized Medical Center Institutional Review Board.
Requesters must provide a methodologically sound proposal and sign a data access agreement.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
- ICF
- CODICE_ANALITICO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .